| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0024312|lymphopenia |
| Sentences | 1 |
| PubMedID- 21339260 | This treatment regimen is often associated with significant lymphopenia, thrombocytopenia, and progressive blood-brain barrier dysfunction that can result in clinical and radiologic deterioration without true tumor progression ("pseudoprogression"). |
Page: 1